These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2275890)

  • 1. Sotalol versus class I and II antiarrhythmic agents.
    Hanyok JJ; MacNeil DJ
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():603-11. PubMed ID: 2275890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
    Chandraratna PA
    Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of sotalol for therapy of complex ventricular arrhythmias and comparisons with placebo and class I antiarrhythmic drugs.
    Anderson JL
    Am J Cardiol; 1990 Jan; 65(2):37A-42A; discussion 51A-52A. PubMed ID: 2403734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P; Newman D; Berman N; Hardy J; Mitchell J
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia.
    Kubac G; Klinke WP; Grace M
    Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes.
    Deedwania PC
    Am J Cardiol; 1990 Jan; 65(2):43A-50A; discussion 51A-52A. PubMed ID: 1688482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sotalol Is More Powerful Than Propranolol in Suppressing Complex Ventricular Arrhythmias.
    Deedwania PC
    J Cardiovasc Pharmacol Ther; 1997 Oct; 2(4):259-272. PubMed ID: 10684467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol.
    Advani SV; Singh BN
    Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography.
    Mahmarian JJ; Verani MS; Hohmann T; Hill R; Thornton BC; Bolli R; Young JB; Roberts R; Pratt CM
    Circulation; 1987 Aug; 76(2):324-31. PubMed ID: 3301053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of sotalol for life-threatening ventricular arrhythmias.
    Roden DM
    Am J Cardiol; 1993 Aug; 72(4):51A-55A. PubMed ID: 8346727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.